Compound Detail
CHEMBL2141296
IXAZOMIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL2141296 |
| Name | IXAZOMIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | MXAYKZJJDUDWDS-LBPRGKRZSA-N |
| Therapeutic | ✓ Yes |
14
Targets
28
Activities
2
Assay Types
1
PK Parameters
20
Publications
4
Known Names
20
Indications
1
Mechanisms
Molecular Properties
361.0
MW (Da)
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| 26S proteasome inhibitor | INHIBITOR | 26S proteasome | ✓ | ✓ |
Indications
Neoplasms Neoplasms Amyloidosis, Familial Multiple Myeloma Plasmacytoma Anemia, Hemolytic, Autoimmune Hematologic Neoplasms Leukemia Lymphoma, Follicular Lymphoma, Mantle-Cell Purpura, Thrombocytopenic, Idiopathic Renal Insufficiency, Chronic Waldenstrom Macroglobulinemia Carcinoma, Renal Cell HIV Infections Leukemia, Myeloid, Acute Lupus Nephritis Lymphoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Precursor Cell Lymphoblastic Leukemia-Lymphoma
ATC Classification
L01XG03
ixazomib
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
IC50 27 meas. best 8.54
EC50 1 meas. best 5.44
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Proteasome Macropain subunit MB1 CHEMBL4662 | IC50 | 8.54 | 8.3757 | 2.9 | 7 |
| Proteasome component C5 CHEMBL4208 | IC50 | 8.52 | 7.8467 | 3.0 | 3 |
| Proteasome CHEMBL612443 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
| Nuclear factor NF-kappa-B complex CHEMBL2094258 | IC50 | 8.21 | 8.21 | 6.2 | 1 |
| 20S proteasome CHEMBL3831201 | IC50 | 8.19 | 7.8767 | 6.5 | 3 |
| RPMI-8226 CHEMBL614882 | IC50 | 8.13 | 7.695 | 7.4 | 2 |
| Proteasome Macropain subunit CHEMBL3492 | IC50 | 7.52 | 6.1467 | 30.0 | 3 |
| MDA-MB-231 CHEMBL400 | IC50 | 7.37 | 7.37 | 42.6 | 1 |
| U-266 CHEMBL2366315 | IC50 | 7.28 | 7.28 | 52.1 | 1 |
| ARH-77 CHEMBL2366241 | IC50 | 7.18 | 7.18 | 65.5 | 1 |
| MCF7 CHEMBL387 | IC50 | 6.87 | 6.87 | 135.2 | 1 |
| NACHT, LRR and PYD domains-containing protein 3 CHEMBL3779755 | IC50 | 6.7 | 6.7 | 199.5 | 1 |
| BT-549 CHEMBL614072 | IC50 | 6.64 | 6.64 | 227.3 | 1 |
| ATP-dependent Clp protease proteolytic subunit CHEMBL1932910 | EC50 | 5.44 | 5.44 | 3600.0 | 1 |
| ATP-dependent Clp protease proteolytic subunit CHEMBL1932910 | IC50 | 5.28 | 5.28 | 5300.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| F | 27.8 | % | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine